Filgrastim-Teva
Filgrastim-Teva is a biosimilar from Teva Pharma AG and is listed on the FOPH Specialities List. As the follow-on product of a biologic it is reimbursed by basic health insurance. The public price ranges from CHF 78.85 to CHF 465.50 depending on the pack; the co-payment is 10 per cent.
Core data
- Authorisation holder
- Teva Pharma AG
- ATC code
- L03AA02
- IT group
- 06.07.30 Andere
- Active substances
- Filgrastimum ADNr
- Preparation type
- Biosimilar
- On the SL since
- 01/03/2010
- Last price change
- 01/12/2024
- Co-payment
- 10%
Prices per pack
The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.
| Dosage form | Pack size | Ex-factory price | Public price | Valid from | Cat. | GTIN |
|---|---|---|---|---|---|---|
| Inj Lös 30 Mio E/0.5ml | Fertigspr 0.5 ml | CHF 57.43 | CHF 78.85 | 01/03/2010 | A | 7680607220013 |
| Inj Lös 30 Mio E/0.5ml | 5 Fertigspr 0.5 ml | CHF 293.98 | CHF 335.45 | 01/03/2010 | A | 7680607220020 |
| Inj Lös 48 Mio E/0.8ml | Fertigspr 0.8 ml | CHF 82.76 | CHF 106.40 | 01/03/2010 | A | 7680607220044 |
| Inj Lös 48 Mio E/0.8ml | 5 Fertigspr 0.8 ml | CHF 413.82 | CHF 465.50 | 01/03/2010 | A | 7680607220051 |
Limitation
This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.
The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.
FILGRASTIM ist indiziert für die Mobilisierung von Vorläuferzellen des peripheren Blutes (PBPC) vor einer Leukapherese, um bei Patienten mit myelosuppressiver Behandlung durch eine Transplantation solcher Zellen die hämatologische Wiederherstellung zu beschleunigen.
Schwere kongenitale Neutropenie (Kostman Syndrom), zyklische Neutropenie, chronische idiopathische Neutropenie (Langzeitanwendung zur Erhöhung der neutrophilen Granulozytenzahl Bereich 1000 bis 3000 Granulozyten pro mcl und Reduktion der Infektionen bei Kindern und Erwachsenen mit klinisch signifikanten Infektionen während der vergangenen 12 Monate und dreimalig dokumentierter schwerster Neutropenie (< 0.5 x 10^9 ANC/l) während 6 Monaten und nach Ausschluss von reaktiv bedingten Neutropenien Vitamin B12 Mangel, Autoimmunkrankheiten).
More preparations in this group
FAQ
Is Filgrastim-Teva covered by Swiss health insurance?
Yes, but only under conditions. Filgrastim-Teva is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.
What does Filgrastim-Teva cost in Switzerland?
The public price is the maximum price set by the FOPH and for Filgrastim-Teva ranges from CHF 78.85 to CHF 465.50 per pack. The ex-factory price ranges from CHF 57.43 to CHF 413.82. Pharmacies may not charge more, but may charge less.
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages